DRP Journal

Myovant Sciences (NYSE:MYOV) Enters Collaboration With Pfizer Inc. (NYSE:PFE) for Development and Commercialization of ORGOVYX™

December 31, 2020December 31, 2020 DRP Staff 0 Comments Andy Schmeltz, Lynn Seely, Myovant Sciences, Myovant Sciences (NYSE:MYOV), NYSE:MYOV, NYSE:PFE, Pfizer Inc., Pfizer Inc. (NYSE:PFE), relugolix

Myovant Sciences (NYSE:MYOV) has announced a collaboration with Pfizer Inc. (NYSE:PFE) for the development and commercialization of relugolix (ORGOVYX) in